首页> 外文会议>International Conference on Practical Applications of Computational Biology Bioinformatics >Proposal of a New Bioinformatics Pipeline for Metataxonomics in Precision Medicine
【24h】

Proposal of a New Bioinformatics Pipeline for Metataxonomics in Precision Medicine

机译:精密医学中的新生物信息学管道的提议

获取原文
获取外文期刊封面目录资料

摘要

Microbes are found all over the human body and they have a direct impact on the immune system, metabolism and homeostasis. The homeostatic balance of the intestinal microflora can be broken under certain conditions, a situation known as dysbiosis, which can lead to disease, including certain types of cancer, or even affect a patient response to a therapeutic treatment. Metataxonomics pursues the identification of the bacteria species that are present in biological samples of interest, through the sequencing of the 16S rRNA gene, a highly conserved genetic marker that is present in most prokaryotes. Interactions between the microbiota and the human host are being very relevant in the expansion of precision medicine and cancer research, to better predict the risk of disease and to implement bacteria-directed therapeutics. In order to take metataxonomics to the clinic, efficient bioinformatics pipelines are required, that are flexible and portable, and that are able to classify groups of biological samples according to microbiome diversity. With this objective in mind, we propose a new bioinformatics pipeline to analyze biological samples obtained through NGS of the 16S rRNA gene, doing all the required quality checks and computational calculations. The results obtained with this pipeline are aimed to be interpreted together with host DNA exome or RNA-Seq studies and clinical data, to improve the knowledge about the potential reasons that could lead to disease or to a worst patient treatment response.
机译:在人体上发现微生物,它们对免疫系统,新陈代谢和稳态有直接影响。在某些条件下,肠道微血糖的稳态平衡可能被打破,这种情况被称为脱敏,这可能导致疾病,包括某些类型的癌症,甚至影响对治疗治疗的患者的反应。迈得·克科米学追求鉴定患者生物样本中存在的细菌物种,通过16S rRNA基因的测序,是在大多数原核生物中存在的高度保守的遗传标记。微生物群和人宿主之间的相互作用在扩大精确药物和癌症研究方面是非常相关的,更好地预测疾病的风险和实施细菌的治疗。为了将临床统计学应用于临床,需要有效的生物信息学管道,这是灵活和便携的,并且能够根据微生物组多样性对生物样品组进行分类。凭借这一目标,我们提出了一种新的生物信息学管道,用于分析通过16S rRNA基因的NG获得的生物样本,做出所有所需的质量检查和计算计算。用该管道获得的结果旨在与宿主DNA外壳或RNA-SEQ研究和临床数据一起解释,以改善关于可能导致疾病或最糟糕的患者治疗反应的潜在原因的知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号